ARTICLE
1 April 2024

Private Equity Investments In Healthcare (Video)

BI
Buchanan Ingersoll & Rooney PC

Contributor

With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
In this presentation, Buchanan attorneys Andrew Weissenberg, Carly Barnes and Carrie Amezcua delved into the reasons behind private equity's keen interest in healthcare targets.
United States Corporate/Commercial Law

In this presentation, Buchanan attorneys Andrew Weissenberg, Carly Barnes and Carrie Amezcua delved into the reasons behind private equity's keen interest in healthcare targets.

Attendees gained valuable insights into the mechanisms and documents commonly used in medical and dental acquisitions, discovered the intricacies of post-closing structures utilized by private equity firms to ensure ongoing profitability, uncovered new laws affecting private equity purchases of medical practices, and learned how to navigate the complexities of restrictive corporate practice of medicine prohibitions across different states.

View the recording here or below.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More